What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2021-08-12 compared with 2020-08-13 · 39 added, 38 removed, 10 unchanged (89% of the section changed)

MARKET FOR REGISTRANT’S COMMON

EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET FOR REGISTRANT’S COMMON EQUITY,

RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is quoted on the OTC pink

sheets under the symbol “RCAT”.

The over-the-counter market quotations reflect

inter-dealer prices, without retail mark-up, mark-down or commission, and may not represent actual transactions.

The last reported sales price of our common

stock on August 5, 2020, was $0.99.

As of August 5, 2020, there were 584 stockholders

of record of our common stock.

The Company has never paid dividends on its

common stock and does not anticipate that it will pay dividends in the foreseeable future.

It intends to use any future earnings

for the expansion of its business.

Any future determination of applicable dividends will be made at the discretion of the board

of directors and will depend on the results of operations, financial condition, capital requirements and other factors deemed relevant.

Securities Authorized for Issuance Under

Equity Compensation Plan

Our common stock is trading on the Nasdaq Capital

Market (“Nasdaq”) since April 30, 2021 under the symbol “RCAT

The last reported sales price of our common stock

on August 9, 2021 was $3.17.

As of August 9, 2021, there were 587

stockholders of record of our common stock.

The Company has never paid dividends on its common

stock and does not anticipate that it will pay dividends in the foreseeable future.

It intends to use any future earnings for the expansion

of its business.

Any future determination of applicable dividends will be made at the discretion of the board of directors and will depend

on the results of operations, financial condition, capital requirements and other factors deemed relevant.

Securities Authorized for Issuance Under Equity

Compensation Plan

The following table provides information regarding

our equity compensation plans as of April 30, 2021:

Equity Compensation Plan Information

Equity Compensation Plan

Plan category

of securities to be issued upon exercise of outstanding options, warrants and rights

Weighted-average

exercise price of outstanding options, warrants and rights

of securities remaining available for future issuance under equity compensation plans

Number of securities

to be issued upon exercise of outstanding options, warrants, and vesting of restricted stock

Weighted-average exercise

price of outstanding options and warrants

Number of securities

remaining available for future issuance under equity compensation plans

Equity compensation plans approved by security holders

Equity compensation plans not approved by security

3,197,475 (1)

Equity compensation plans not approved by security holders

______________

Represents stock options issued under the Company’s 2019 Equity

1 unchanged sentence

Recent Sales of Unregistered Securities

Except as set forth

below, there were no sales of equity securities during the period covered by this Annual Report that were not registered under

the Securities Act and were not previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by

In May 2019, the

Company issued 1,570 shares of common stock, with a fair value of $70,000, to a law firm for services provided to the Company.

In August 2019,

the Company issued 469,847 shares of common stock upon the exercise of a warrant and received proceeds of

In April 2019,

the Company issued 150,000 shares of common stock with a fair value of $204,000 to a law firm for services provided to the Company.

The above issuances

did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe are exempt from

the registration requirements of the Securities Act of 1933 by virtue of Section 4(2) thereof.

Except as set forth below,

there were no sales of equity securities during the period covered by this Annual Report that were not registered under the Securities

Act and were not previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the Company.

In May 2019, the Company

issued 1,570 shares of common stock, with a fair value of $70,000, to a law firm for services provided to the Company.

In August 2019, the Company

issued 469,847 shares of common stock upon the exercise of a warrant and received proceeds of $152,239.

In April 2019, the Company

issued 150,000 shares of common stock with a fair value of $204,000 to a law firm for services provided to the Company.

The above issuances did

not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe are exempt from the registration

requirements of the Securities Act of 1933 by virtue of Section 4(2) thereof.

SELECTED FINANCIAL DATA

As a smaller reporting company, we are not

required to provide this information.

As a smaller reporting company, we are not required

to provide this information.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity